title: Is coronary thrombolysis associated with side effects that significantly compromise clinical benefits?
authors.affiliation: Vascular Research Laboratory, Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
authors.forename: V
authors.initials: V
authors.lastname: Gurewich
authors.forename: J
authors.initials: J
authors.lastname: Muller
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000628:therapy; D013300:Streptokinase / Q000009:adverse effects; D015996:Survival Rate; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D013300:Streptokinase; D010959:Tissue Plasminogen Activator